Medicines and Healthcare Products Regulatory Agency
Program Name
PhD in Chemistry
Deadline
February 09th, 2026
Overview
Title: Appraisal of the immunotherapeutic and immunotoxicological properties of mRNA-based in vivo CAR T-cell engineering for cancer treatment/nA 4-year full-time PhD studentship is available from October 2026 in Biotherapeutics and Advanced Therapies Team within the Science, Research and Innovation operational group (SR&I) of the Medicines and Healthcare Products Regulatory Agency (MHRA) in collaboration with the UCL Department of Chemistry./nLocation: United Kingdom/nFunding: Funded PhD Project (UK Students Only)/nUpdated date: 22 December 2025
Duration
4 Months
Application Requirements
Here's everything you need to know to ensure a complete and competitive application—covering the key documents and criteria for a successful submission.
Application Deadlines
| Default | |
|---|---|
| Spring | Feb 9, 2026 |
Ready to elevate your study abroad journey?
Book a call with us now and take the first step towards your global future!
Connect with us on our social media
